Inventor · disambiguated record
Richard Preston Mason
Also filed as: MASON RICHARD PRESTON
4 granted patents·17 pending applications·0 citations·filing 2013–2023
57Inventor score
Top patents by PatentIndex Score
21 records- 0167US2022142962A1Methods of treating hypercholesterolemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2022·Application pending·0 cites
- 0266US10842765B2Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Nov 24, 2020·0 cites·13 claims
- 0358US11446269B2Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted Sep 20, 2022·0 cites·5 claims
- 0458US10406130B2Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Sep 10, 2019·0 cites·12 claims
- 0558US2021085629A1Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 0658US2014249225A1Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 0756US2020289450A1Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 0856US2020237699A1Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 0955US2024165066A1Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatmentAMARIN PHARMACEUTICALS IE LTD·Filed 2023·Application pending·0 cites
- 1054US2020061011A1Methods of treating hypercholesterolemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Application pending·0 cites
- 1152US2019060308A1Pharmaceutical composition comprising an omega-3 fatty acid and a hydroxy-derivative of a statin and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Application pending·0 cites
- 1251US2013324607A1Methods of treating hypercholesterolemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Application pending·0 cites
- 1351US2020237700A1Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 1451US2014080850A1Pharmaceutical composition comprising an omega-3 fatty acid and a hydroxy-derivative of a statin and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Application pending·0 cites
- 1550US10172818B2Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 8, 2019·0 cites·12 claims
- 1649US2024173285A1Compositions comprising epa and methods of using the same for treating and/or preventing endothelial dysfunction in a subjectMASON RICHARD PRESTON·Filed 2022·Application pending·0 cites
- 1746US2017151202A1Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acidsAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Application pending·0 cites
- 1843US2015250756A1Methods of treating hypercholesterolemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Application pending·0 cites
- 1941US2019054054A1Methods reducing or preventing oxidation of high density lipoprotein (HDL)AMARIN PHARMACEUTICALS IE LTD·Filed 2018·Application pending·0 cites
- 2037US2019209506A1Methods of reducing or preventing oxidation of ldl or lipid membranes in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Application pending·0 cites
- 2128US2018028480A1Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acidsMASON RICHARD PRESTON·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Preston Mason files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →